Eye Tracking and Autism in Former Preterm Infants
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14-48
SponsorIndiana University
About this trial
This is a single center, intervention study of integrating the eye-tracking (ET) biomarker battery into the existing autism evaluation process at the Riley Early Years Program (EYP). Eligible participants referred for autism testing through EYP will undergo a traditional comprehensive diagnostic assessment by an EYP clinical psychologist.
Eligibility criteria
Qualifiers
Children born at <37 weeks' gestational age who are 14-48 months old at time of referral
Ambulatory (i.e., cruising, walking)
Without significant visual impairment
Referred for autism testing through EYP (i.e. medium- or high-risk M-CHAT-R/F screening result at 16-22 months corrected age or by referral to Early Years based on caregiver or provider concern for autism)
Disqualifiers
Non-English-speaking participants and families.
Trial design
Treatments tested in this trial
- Eye-tracking device
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Indiana University
Lead sponsor
Indiana University Health
Collaborator
Source ClinicalTrials.gov